This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (AMED) Outperforming Other Medical Stocks This Year?
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Here's Why You Should Snap Up Abbott (ABT) Stock Right Now
by Zacks Equity Research
We are optimistic about the strong and consistent performance of Abbott's (ABT) EPD segment. The company's Diabetes Care business has been hogging the limelight on strength in FreeStyle Libre.
Thermo Fisher (TMO) Down on Business Divestment Declaration
by Zacks Equity Research
Thermo Fisher's (TMO) Anatomical Pathology business comes under its Specialty Diagnostics segment catering to customers at healthcare and clinical laboratories.
Here's Why You Should Buy Tandem Diabetes (TNDM) Stock Now
by Zacks Equity Research
Strength in domestic sales along with the recent launch of the t:slim X2 Insulin Pump in selected international markets bode well for Tandem Diabetes (TNDM).
Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Shoe Carnival, Amedisys, Expeditors International of Washington and Stitch Fix
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Shoe Carnival, Amedisys, Expeditors International of Washington and Stitch Fix
Henry Schein Animal Health Spin-Off Approaches, Costs Mount (revised)
by Zacks Equity Research
Henry Schein's (HSIC) animal health spin-off will help it boost growth opportunities in dental space to deliver quality clinical care plus advanced wellness and prevention.
Bet on DuPont Analysis: Play 5 Quality Stocks
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
Quest Diagnostics' Core Diagnostics Strong Amid Several Woes
by Zacks Equity Research
Quest Diagnostics' (DGX) steady efforts to intensify focus on core diagnostic information services business and an intelligent capital management give investors ample reasons to cheer for.
Amedisys (AMED) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Amedisys (AMED) closed at $127 in the latest trading session, marking a +0.09% move from the prior day.
Can Medical Devices Strength Drive Abbott (ABT) Q4 Earnings?
by Zacks Equity Research
Abbott (ABT) Q4 results likely to show continued growth in Medical Devices business.
Here's Why You Should Buy Myriad Genetics (MYGN) Stock Now
by Zacks Equity Research
On the success of the Elevate 2020 program, along with augmenting reimbursements for tests, Myriad Genetics (MYGN) seems to be well-positioned to deliver strong financial results in fiscal 2019.
Henry Schein Animal Health Spin-Off Approaches, Cost Mounts
by Zacks Equity Research
Henry Schein's (HSIC) animal health spin-off will help it boost growth opportunities in dental space to deliver quality clinical care plus advanced wellness and prevention.
Why You Should Consider Buying Omnicell (OMCL) Stock Now
by Zacks Equity Research
Omnicell (OMCL) is pulling out all the stops to strengthen the medication adherence segment.
QIAGEN QFT-Plus Ok'd in Canada, Test Customer Base Expands
by Zacks Equity Research
QIAGEN (QGEN) progresses with plans to widen customer base for QuantiFERON-TB Gold Plus test.
Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (AMED) Outperforming Other Medical Stocks This Year?
Here's Why You Should Invest in Illumina (ILMN) Stock Now
by Zacks Equity Research
Illumina's (ILMN) product launches continue to contribute to the top line. The company's recent broadening of genotyping sequencing line buoys optimism.
New Strong Buy Stocks for January 10th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Zacks.com featured expert Kevin Matras highlights: Amedisys, Foot Locker, Shoe Carnival, Tractor Supply and Caseys General Stores
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Amedisys, Foot Locker, Shoe Carnival, Tractor Supply and Caseys General Stores
Zacks.com featured expert Kevin Matras highlights: Helmerich & Payne, Manulife Financial, HEICO, Amedisys and Titan Machinery
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Helmerich & Payne, Manulife Financial, HEICO, Amedisys and Titan Machinery
Zacks.com featured expert Kevin Matras highlights: BJ's Restaurants, O'Reilly Automotive, Amedisys, HCA Healthcare and Toyota Motor
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: BJ's Restaurants, O'Reilly Automotive, Amedisys, HCA Healthcare and Toyota Motor
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
5 Quality Stock Picks Based on DuPont Analysis
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived from the DuPont way.
Buy These 5 Low Leverage Stocks to Stay Away From Debt Traps
by Zacks Equity Research
Since debt-ridden companies are more vulnerable at times of crisis, it is better to avoid those. Of course, entirely avoiding companies with debt loads is virtually impossible.
Here Are 5 Stocks With Amazing Interest Coverage Ratio
by Zacks Equity Research
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charged on its debt.